RGT 2.00% 25.5¢ argent biopharma limited

Ann: US Market Update - CimetrA Clinical Trial Progress, page-2

  1. 7,371 Posts.
    lightbulb Created with Sketch. 2827
    They are trying their best to get some news out and get the price up, agree with others it might be time for a CR given they are trying to pump price, always a pattern in the past.

    Theres a good possible buy for them in Australia right now:

    https://www.cbre.com.au/properties/...unceston-northern-cressy-tas-7302?view=isSale



    ECS selling one of its outdoor cultivation sites to focus on one location thats already cashflow positive. I bet could pick this up for bargain prices, given the current market and state of cannabis ETFs.

    All the ground work basically done, as they say " fully operational medicinal cannabis production enterprise " turn-key, complete ready for immediate use, can just buy it and be a competitor of ECS.

    It really is great opportunity for anyone wanting to get into the space or an existing company to get a low cost cultivation operation going.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
25.5¢
Change
0.005(2.00%)
Mkt cap ! $12.34M
Open High Low Value Volume
24.0¢ 25.5¢ 24.0¢ $137.1K 549.1K

Buyers (Bids)

No. Vol. Price($)
1 2200 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 100 1
View Market Depth
Last trade - 16.10pm 20/08/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.